JP2015525237A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015525237A5 JP2015525237A5 JP2015518318A JP2015518318A JP2015525237A5 JP 2015525237 A5 JP2015525237 A5 JP 2015525237A5 JP 2015518318 A JP2015518318 A JP 2015518318A JP 2015518318 A JP2015518318 A JP 2015518318A JP 2015525237 A5 JP2015525237 A5 JP 2015525237A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- composition
- seq
- modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2012-0066527 | 2012-06-21 | ||
| KR20120066527 | 2012-06-21 | ||
| PCT/KR2013/000983 WO2013191352A1 (en) | 2012-06-21 | 2013-02-07 | New uses of modified human tumor necrosis factor receptor-1 polypeptide |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015525237A JP2015525237A (ja) | 2015-09-03 |
| JP2015525237A5 true JP2015525237A5 (https=) | 2016-04-28 |
| JP6087429B2 JP6087429B2 (ja) | 2017-03-01 |
Family
ID=49768924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015518318A Active JP6087429B2 (ja) | 2012-06-21 | 2013-02-07 | 変形されたヒト腫瘍壊死因子受容体−１ポリペプチドの新規用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9580490B2 (https=) |
| JP (1) | JP6087429B2 (https=) |
| KR (1) | KR101514238B1 (https=) |
| CN (1) | CN104394881B (https=) |
| BR (1) | BR112014031923B1 (https=) |
| WO (1) | WO2013191352A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10508134B2 (en) | 2015-05-01 | 2019-12-17 | Onl Therapeutics, Inc. | Peptide compositions and methods of use |
| CN109311976A (zh) | 2016-06-20 | 2019-02-05 | 诺华股份有限公司 | 使用TNFα拮抗剂治疗干眼症的方法 |
| KR20230131212A (ko) | 2021-01-14 | 2023-09-12 | 한올바이오파마주식회사 | 안정화제를 사용하지 않고도 안정한, 탄파너셉트를포함하는 안과용 조성물 |
| TWI905137B (zh) * | 2021-01-14 | 2025-11-21 | 南韓商韓兀生物製藥股份有限公司 | 以含有天凡諾賽普特（ｔａｎｆａｎｅｒｃｅｐｔ）之眼用組成物治療乾眼症 |
| WO2022154142A1 (ko) * | 2021-01-14 | 2022-07-21 | 주식회사한올바이오파마 | 탄파너셉트 안과용 조성물을 이용한 안구건조증의 치료 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000027421A2 (en) | 1998-11-06 | 2000-05-18 | The Schepens Eye Research Institute, Inc. | LOCAL USE OF SOLUBLE TUMOR NECROSIS RECEPTOR I (sTNFRI) FOR PROPHYLAXIS AND TREATMENT OF CORNEAL TRANSPLANT REJECTION AND OTHER DISORDERS OF THE EYE |
| US6379666B1 (en) | 1999-02-24 | 2002-04-30 | Edward L. Tobinick | TNF inhibitors for the treatment of neurological, retinal and muscular disorders |
| US6177077B1 (en) | 1999-02-24 | 2001-01-23 | Edward L. Tobinick | TNT inhibitors for the treatment of neurological disorders |
| US6204270B1 (en) | 1999-11-12 | 2001-03-20 | Eyal S. Ron | Ophthalmic and mucosal preparations |
| WO2004009776A2 (en) | 2002-07-19 | 2004-01-29 | Abbott Biotechnology Ltd. | TREATMENT OF TNFα RELATED DISORDERS |
| US20090098136A1 (en) * | 2007-10-15 | 2009-04-16 | Alcon Research, Ltd. | Use of tnf receptor antagonists for treating dry eye |
| CN101591388A (zh) * | 2008-05-30 | 2009-12-02 | 上海复旦张江生物医药股份有限公司 | 一种可溶性tnf受体突变体 |
| EP2492281B1 (en) * | 2009-10-19 | 2018-04-11 | HanAll Biopharma Co., Ltd. | Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same |
| KR101273893B1 (ko) | 2010-09-13 | 2013-06-14 | 한올바이오파마주식회사 | 변형된 인간 종양 괴사 인자 수용체-1 폴리펩티드 또는 그의 절편 및 그의 제조방법 |
| PL2657252T3 (pl) | 2010-12-23 | 2017-08-31 | Hanall Biopharma Co., Ltd. | Modyfikowany polipeptyd ludzkiego receptora-1 czynnika martwicy nowotworu lub jego fragment i sposób ich wytwarzania |
-
2013
- 2013-02-07 JP JP2015518318A patent/JP6087429B2/ja active Active
- 2013-02-07 US US14/404,001 patent/US9580490B2/en active Active
- 2013-02-07 KR KR1020130014076A patent/KR101514238B1/ko active Active
- 2013-02-07 CN CN201380032597.1A patent/CN104394881B/zh active Active
- 2013-02-07 BR BR112014031923-5A patent/BR112014031923B1/pt active IP Right Grant
- 2013-02-07 WO PCT/KR2013/000983 patent/WO2013191352A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015525237A5 (https=) | ||
| WO2011123830A3 (en) | Alpha 1-antitrypsin compositions and methods of making and using same | |
| WO2019035880A8 (en) | EXOSOMES OF PURIFIED MESENCHYMAL STEM CELLS AND USES THEREOF | |
| JP2012115277A5 (https=) | ||
| EA201890220A1 (ru) | Вакцина против rsv | |
| BRPI1010880A2 (pt) | polipeptídeos de hormônio de crescimento e métodos de fazer e usar os mesmos. | |
| WO2011157713A4 (en) | Cell-penetrating peptides and uses therof | |
| PE20240015A1 (es) | Proteinas de fusion gdf15 y usos de estas | |
| NL2011626C2 (en) | Novel polypeptide and uses thereof. | |
| WO2013151670A3 (en) | Modified polynucleotides for the production of nuclear proteins | |
| EA201101553A1 (ru) | Полипептид, деградирующий углеводы, и его применения | |
| JP2015522264A5 (https=) | ||
| PE20150923A1 (es) | Moleculas de union il-17a novedosas y usos medicos de las mismas | |
| EA201170917A1 (ru) | Ген, кодирующий мутантную глюкокиназу человека, кодируемый им фермент, рекомбинантные векторы и хозяева, фармацевтические композиции и их применения, способы лечения и предупреждения болезней | |
| ATE506957T1 (de) | Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen | |
| JP2017529326A5 (https=) | ||
| Ma et al. | Identification, expression and activity analyses of five novel duck beta-defensins | |
| WO2009089822A3 (de) | Verwendung eines acetylsalicylsäuresalzes zur behandlung viraler infektionen | |
| RU2015102027A (ru) | Проникающие в клетку пептиды и способы идентификации проникающих в клетку пептидов | |
| JP2016513471A5 (https=) | ||
| EP2465935A3 (en) | Recombinant human interferon-like proteins | |
| PE20210918A1 (es) | Composiciones y metodos para el tratamiento de la distrofia macular | |
| AR060960A1 (es) | Peptido, polinucleotico, secuencia celula transgenica, huesped viral, celula huesped, vector de expresion, uso y metodo de antagonistas de alta afinidad de quimioquinas elr- cxc | |
| JP2018529626A5 (https=) | ||
| JP2013529916A5 (https=) |